Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 235

1.

CD28H expression identifies resident memory CD8 + T cells with less cytotoxicity in human peripheral tissues and cancers.

Tian Y, Sun Y, Gao F, Koenig MR, Sunderland A, Fujiwara Y, Torphy RJ, Chen L, Edil BH, Schulick RD, Zhu Y.

Oncoimmunology. 2018 Nov 5;8(2):e1538440. doi: 10.1080/2162402X.2018.1538440. eCollection 2019.

PMID:
30713797
2.

Recurrent Solid Pseudopapillary Neoplasm of Pancreas: Case Report and Review of Literature.

Sharma PK, Mehrotra S, Gleisner AL, Schulick RD, McCarter MD.

J Pancreat Cancer. 2018 Jun 1;4(1):25-29. doi: 10.1089/pancan.2018.0006. eCollection 2018.

3.

Use of Total Pancreatectomy and Preoperative Radiotherapy in Patients Undergoing Pancreatectomy with Artery Resection.

Del Chiaro M, Schulick RD.

J Am Coll Surg. 2019 Jan;228(1):131. doi: 10.1016/j.jamcollsurg.2018.10.016. No abstract available.

PMID:
30580801
4.

Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity.

Fujiwara Y, Sun Y, Torphy RJ, He J, Yanaga K, Edil BH, Schulick RD, Zhu Y.

Cancer Res. 2018 Dec 1;78(23):6655-6665. doi: 10.1158/0008-5472.CAN-18-1781. Epub 2018 Oct 12.

PMID:
30315115
5.

Microfluidics contrasted to thrombelastography: perplexities in defining hypercoagulability.

Lawson PJ, Moore HB, Moore EE, Gerich ME, Stettler GR, Banerjee A, Schulick RD, Nydam TL.

J Surg Res. 2018 Nov;231:54-61. doi: 10.1016/j.jss.2018.04.059. Epub 2018 Jun 8.

6.

Immunotherapy for pancreatic cancer: Barriers and breakthroughs.

Torphy RJ, Zhu Y, Schulick RD.

Ann Gastroenterol Surg. 2018 Jun 22;2(4):274-281. doi: 10.1002/ags3.12176. eCollection 2018 Jul. Review.

7.

Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma.

Chapman BC, Gleisner A, Rigg D, Messersmith W, Paniccia A, Meguid C, Gajdos C, McCarter MD, Schulick RD, Edil BH.

JOP. 2018 Mar;19(2):75-85. Epub 2018 Mar 30.

8.

Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.

Canto MI, Almario JA, Schulick RD, Yeo CJ, Klein A, Blackford A, Shin EJ, Sanyal A, Yenokyan G, Lennon AM, Kamel IR, Fishman EK, Wolfgang C, Weiss M, Hruban RH, Goggins M.

Gastroenterology. 2018 Sep;155(3):740-751.e2. doi: 10.1053/j.gastro.2018.05.035. Epub 2018 May 24.

PMID:
29803839
9.

Comparing Short-term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers.

Torphy RJ, Friedman C, Halpern A, Chapman BC, Ahrendt SS, McCarter MM, Edil BH, Schulick RD, Gleisner A.

Ann Surg. 2018 May 16. doi: 10.1097/SLA.0000000000002810. [Epub ahead of print]

PMID:
29771723
10.

Utility of Viscoelastic Assays Beyond Coagulation: Can Preoperative Thrombelastography Indices Predict Tumor Histology, Nodal Disease, and Resectability in Patients Undergoing Pancreatectomy?

Moore HB, Paniccia A, Lawson PJ, Torphy RJ, Nydam TL, Moore EE, McCarter MD, Schulick RD, Edil BH.

J Am Coll Surg. 2018 Jul;227(1):55-62. doi: 10.1016/j.jamcollsurg.2018.03.031. Epub 2018 Mar 30.

PMID:
29605725
11.

Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pancreatic adenocarcinoma.

Chapman BC, Gleisner A, Rigg D, Meguid C, Goodman K, Brauer B, Gajdos C, Schulick RD, Edil BH, McCarter MD.

J Surg Oncol. 2018 Apr;117(5):1073-1083. doi: 10.1002/jso.25004. Epub 2018 Feb 15.

PMID:
29448308
12.

Newly Emerging Immune Checkpoints: Promises for Future Cancer Therapy.

Torphy RJ, Schulick RD, Zhu Y.

Int J Mol Sci. 2017 Dec 6;18(12). pii: E2642. doi: 10.3390/ijms18122642. Review.

13.

Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial?

Torphy RJ, Schulick RD.

Surg Clin North Am. 2018 Feb;98(1):25-35. doi: 10.1016/j.suc.2017.09.003. Review.

PMID:
29191275
14.

Comparison of laparoscopic to open pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma.

Chapman BC, Gajdos C, Hosokawa P, Henderson W, Paniccia A, Overbey DM, Gleisner A, Schulick RD, McCarter MD, Edil BH.

Surg Endosc. 2018 May;32(5):2239-2248. doi: 10.1007/s00464-017-5915-0. Epub 2017 Oct 24.

PMID:
29067580
15.

What We Learned From John Cameron.

Schulick RD.

Ann Surg. 2018 Feb;267(2S Suppl 2):S3-S5. doi: 10.1097/SLA.0000000000002576. No abstract available.

PMID:
29064886
16.

Laparoscopic pancreaticoduodenectomy: changing the management of ampullary neoplasms.

Chapman BC, Gleisner A, Ibrahim-Zada I, Overbey DM, Paniccia A, Meguid C, Brauer B, Gajdos C, McCarter MD, Schulick RD, Edil BH.

Surg Endosc. 2018 Feb;32(2):915-922. doi: 10.1007/s00464-017-5766-8. Epub 2017 Aug 4.

PMID:
28779245
17.

Anaplastic Pancreatic Carcinoma Arising Within a Mucinous Cystic Neoplasm of the Pancreas: A Case Report and a Brief Review of the Literature.

Paniccia A, Torphy R, Devaraj K, Schulick RD.

J Pancreat Cancer. 2017 Jul 1;3(1):40-45. doi: 10.1089/pancan.2017.0004. eCollection 2017.

18.

Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions.

Xu F, Sunderland A, Zhou Y, Schulick RD, Edil BH, Zhu Y.

Cancer Immunol Immunother. 2017 Oct;66(10):1367-1375. doi: 10.1007/s00262-017-2031-x. Epub 2017 Jun 16.

19.

Impact of neoadjuvant chemoradiation on perioperative outcomes in patients with rectal cancer.

Chapman BC, Hosokawa P, Henderson W, Paniccia A, Overbey DM, Messersmith W, Lieu C, Stiegmann GV, Schulick RD, Gajdos C.

J Surg Oncol. 2017 Jun;115(8):1033-1044. doi: 10.1002/jso.24613. Epub 2017 Mar 23.

PMID:
28334436
20.

An institutional analysis of unplanned return to the operating room to identify areas for quality improvement.

Lin Y, Meguid RA, Hosokawa PW, Henderson WG, Hammermeister KE, Schulick RD, Shelstad RC, Wild TT, McIntyre RC Jr.

Am J Surg. 2017 Jul;214(1):1-6. doi: 10.1016/j.amjsurg.2016.10.021. Epub 2016 Dec 13.

PMID:
28057294

Supplemental Content

Loading ...
Support Center